Volume 22, Number 4—April 2016
Chronic Infection of Domestic Cats with Feline Morbillivirus, United States
To the Editor: Feline morbillivirus (FeMV) was first reported in Hong Kong and mainland China in 2012 (1) and has been associated with tubulointerstitial nephritis, the histopathologic correlate of idiopathic chronic kidney disease (CKD); however, this association has not been proven by studies in FeMV-naive animals. In 2013, phylogenetically related strains were found in Japan, indicating broader geographic distribution in Asia (2). The lack of complete genome sequences for strains from other regions prevents assessment of the clinical relevance and genetic diversity of FeMV. Classical morbilliviruses, such as measles and canine distemper viruses, have a global distribution, suggesting that FeMV might be present elsewhere in the world (3). To confirm the presence of FeMV and assess its genetic diversity and infection patterns in the United States, we collected and analyzed urine samples from domestic cats.
We generated amplicons from 10 (3%) of 327 samples; 3 samples were from cats with CKD and 7 from cats without CKD. Sequencing results confirmed that these 493 bp amplicons correspond to unique strains of FeMV (1). FeMVUS1 is 97% similar in the L gene amplicon sequence to FeMV776U (1), whereas FeMVUS5 is only 85% identical, making it very different to all previously identified FeMVs. We used these sequences to develop a pan-US primer set, priFeMVUSpanL+ and priFeMVUSpanL−, to amplify a highly conserved region (460 bp) of the L gene of the US strains (Technical Appendix[PDF - 387 KB - 4 pages] Table 1). The results of these analyses demonstrated that FeMV is present outside of Asia.
In October 2013, we obtained the initial FeMVUS1-positive sample from a healthy 4-year-old male domestic shorthair cat (animal 0213). Approximately 15 months later, we obtained a follow-up urine sample from the still healthy cat, performed reverse transcription PCR (RT-PCR), and generated amplicons (Technical Appendix[PDF - 387 KB - 4 pages] Figure 1, panel A). Amplification and sequencing of the hemagglutinin (H) gene from the 2015 sample indicated that it was identical to that from the 2013 sample, suggesting that the cat was chronically infected. We developed a quantitative RT-PCR test by using L gene primers and a real-time probe (Technical Appendix[PDF - 387 KB - 4 pages] Table 2). Results indicated stable and comparable virus loads: 9.8 × 104 copies/mL in 2013 versus 7.8 × 104 copies/mL in 2015. This finding corroborates the view that cats can be chronically infected with FeMV and that the virus is persistently shed in urine.
We used primers to generate cDNA from clinical material and then determined the complete genome sequence of FeMVUS1 (GenBank accession no. KR014147) by using RT-PCR and rapid amplification of cDNA ends. The major morbillivirus surface antigen is the HA glycoprotein, and we used pan-FeMV HA gene primer sets to detect additional viruses (e.g., FeMVUS2) (Technical Appendix[PDF - 387 KB - 4 pages] Figure 1, panel B). An indirect immunofluorescence assay was developed to screen serum samples for FeMV-specific antibodies. Antibodies to FeMVUS1 were detected in fixed cells expressing FeMV H glycoprotein (positive up to 1:12,800 dilution), and antibodies to FeMVUS5 were detected in nonpermeabilized cells (positive up to 1:6,400 dilution) (Technical Appendix[PDF - 387 KB - 4 pages] Figure 2). This result confirms that H glycoprotein–specific antibodies are present at high levels concurrent with the longitudinal detection of genomic RNA. A large-scale seroprevalence and cross-neutralization study is ongoing.
We used complete genome and H gene sequences in a comprehensive phylogenetic analysis. FeMVUS1 is closely related to viruses from Asia, highlighting the global distribution of FeMV (Figure, panel A). Compared with the sequence for the FeMV776U H gene, sequences for FeMVUS1 and FeMVUS5 were 98% and 81% similar, and the glycoproteins were 98% and 86% identical. The complete H gene of the most divergent US strain (FeMVUS5) clustered phylogenetically in a basal sister relationship with all other viruses from Asia and the United States (Figure, panel B), suggesting a long evolutionary association of FeMV in feline hosts.
Ecologic surveys continue to identify novel viruses that are homologous to known paramyxoviruses in many wildlife species, including bats and rodents (6). Investigating closely related viruses in domestic species is warranted, given the substantial number of animals that cohabitate with humans. Switches from natural to unnatural host species can result in enhanced pathogenicity (e.g., receptor switching has caused feline panleukopenia virus to infect dogs as canine parvovirus) (7). Given the high degree of antigenic relatedness of morbilliviruses, understanding evolutionary origins and trajectories and conferring cross-protection through immunization are critical. Although no evidence for FeMV transmission to humans or other animals exists, the propensity for noncanonical use of signaling lymphocytic activation molecule 1F1 (CD150) should be investigated because epizootic transmission of morbilliviruses can occur (8).
The detection of FeMV sequences in a clinically healthy animal after 15 months is a novel and surprising observation but is consistent with the known propensity for morbilliviruses to persist in vivo (9). All known morbilliviruses cause acute infections, and the typical long-term clinical manifestations occur in the central nervous system, not the urinary system (1). These observations should prompt additional research because the prevalence of CKD in cats is high and because CKD decreases the quality of life of affected animals and is the ultimate cause of death for approximately one third of cats (10).
We thank Florence Lee, Diane Welsh, Karen Greenwood, Graeme Bainbridge, Betsy Galvan, and Rik de Swart for helpful suggestions, critical reading of the manuscript, and technical support. We thank the Winn Foundation for previous support.
Funding for this study was provided by Boston University and Zoetis LLC.
- Woo PC, Lau SK, Wong BH, Fan RY, Wong AY, Zhang AJ, Feline morbillivirus, a previously undescribed paramyxovirus associated with tubulointerstitial nephritis in domestic cats. Proc Natl Acad Sci U S A. 2012;109:5435–40.
- Furuya T, Sassa Y, Omatsu T, Nagai M, Fukushima R, Shibutani M, Existence of feline morbillivirus infection in Japanese cat populations. Arch Virol.2014;159:371–3.
- Nambulli S, Sharp CR, Acciardo AS, Drexler JF, Duprex WP. Mapping the evolutionary trajectories of morbilliviruses: what, where, and whither. Curr Opin Virol. 2016. In press.
- Simmonds P. SSE: a nucleotide and amino acid sequence analysis platform. BMC Res Notes. 2012;5:50.
- Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol. 2011;28:2731–9.
- Drexler JF, Corman VM, Müller MA, Maganga GD, Vallo P, Binger T, Bats host major mammalian paramyxoviruses. Nat Commun. 2012;3:796.
- Parrish CR, Kawaoka Y. The origins of new pandemic viruses: the acquisition of new host ranges by canine parvovirus and influenza A viruses. Annu Rev Microbiol. 2005;59:553–86.
- Ludlow M, Rennick LJ, Nambulli S, de Swart RL, Duprex WP. Using the ferret model to study morbillivirus entry, spread, transmission and cross-species infection. Curr Opin Virol. 2014;4:15–23.
- Rima BK, Duprex WP. Molecular mechanisms of measles virus persistence. Virus Res. 2005;111:132–47.
- Lawler DF, Evans RH, Chase K, Ellersieck M, Li Q, Larson BT, The aging feline kidney: a model mortality antagonist? J Feline Med Surg.2006;8:363–71.
Suggested citation for this article: Sharp CR, Nambulli S, Acciardo AS, Rennick LJ, Drexler JF, Rima BK, et al. Chronic infection of domestic cats with feline morbillivirus, United States [letter]. Emerg Infect Dis. 2016 Apr [date cited]. http://dx.doi.org/10.3201/eid2204.151921